“35. EVALUATING THE RESULT LINE 1 OF TREATMENT NON SMALL CELL LUNG CANCER PATIENTS STAGE IV HABOR EGFR MUTATION BY OSIMERTINIB AT NATIONAL LUNG HOSPITAL FROM 2019 TO 2022”. Vietnam Journal of Community Medicine, vol. 65, no. CĐ 3 - Bệnh viện Phổi Trung ương, May 2024, https://doi.org/10.52163/yhc.v65iCD3.1132.